Bär & Karrer Advises Matterhorn Pharma Holding and Al Faisaliah Group Holding Company on their Partial Public Tender Offer not Subject to the Provisions of Swiss Financial Market Laws and Regulations for Zur Rose Group
On 21 December 2016, Matterhorn Pharma Holding, a company controlled by the Al Faisaliah Group Holding Company, announced a public tender offer for 100'000 to up to a maximum of 400'000 registered shares of Zur Rose Group AG, which is not subject to the provisions of the Swiss financial market laws and regulations. The shares are traded on the platforms eKMU-X of Zürcher Kantonalbank, OTC-X of Berner Kantonalbank and Lienhardt & Partner Privatbank Zürich AG. The settlement of the offer will presumably take place on 20 January 2017. Al Faisaliah Group is a privately owned group with its head office in Riyadh, Saudi Arabia, and holds positions in agriculture and food, electronics & systems, healthcare, pharmaceuticals and food service.
Bär & Karrer acted as Matterhorn Pharma Holding's legal counsel in connection with the partial public tender offer. The team included Dieter Dubs and Fabienne Perlini (both M&A).